×
About 4,183 results

ALLMedicine™ Brugada Syndrome Center

Research & Reviews  2,021 results

Clinical significance of inferolateral early repolarisation and late potentials in chil...
https://doi.org/10.1016/j.jelectrocard.2021.03.011
Journal of Electrocardiology; Lopez-Blazquez M, Field E et. al.

Apr 8th, 2021 - The clinical utility of inferolateral early repolarisation (ER) and late potentials (LP) in children with Brugada Syndrome (BrS) has not been previously evaluated. The aim of this study was to determine the prevalence of electrocardiographic (ECG)...

Single Cell Transcriptomics Trajectory and Molecular Convergence of Clinically Relevant...
https://doi.org/10.1152/ajpheart.00061.2021
American Journal of Physiology. Heart and Circulatory Phy... Tambi R, Abdel Hameid R et. al.

Apr 2nd, 2021 - Brugada syndrome (BrS) is a rare, inherited arrhythmia with high risk of sudden cardiac death. To evaluate the molecular convergence of clinically relevant mutations and to identify developmental cardiac cell types that are associated with BrS eti...

A 32-Year-Old Man Diagnosed with Type II Brugada Syndrome on Preoperative Electrocardio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988432
The American Journal of Case Reports; Yuasa H, Kitaura A et. al.

Mar 19th, 2021 - BACKGROUND Brugada syndrome is a potentially fatal cardiac arrhythmia characterized by incomplete right bundle-branch block (RBB) and characteristic ST-segment elevation in the anterior electrocardiogram (ECG) leads. This report is of a case of ty...

Right ventricular function and dyssynchrony in Brugada syndrome: Highlighting the impor...
https://doi.org/10.1016/j.ijcard.2021.03.014
International Journal of Cardiology; Mitroi C, García-Izquierdo E et. al.

Mar 17th, 2021 - Current evidence suggests that Brugada syndrome (BrS), far from being a purely electrical condition, is associated with subtle mechanical abnormalities primarily affecting the right ventricle (RV). We aimed to characterize RV function in BrS and i...

Structure of human Nav1.5 reveals the fast inactivation-related segments as a mutationa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980460
Proceedings of the National Academy of Sciences of the Un... Li Z, Jin X et. al.

Mar 13th, 2021 - Nav1.5 is the primary voltage-gated Na+ (Nav) channel in the heart. Mutations of Nav1.5 are associated with various cardiac disorders exemplified by the type 3 long QT syndrome (LQT3) and Brugada syndrome (BrS). E1784K is a common mutation that ha...

see more →

Guidelines  1 results

Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventric...
http://circ.ahajournals.org/content/early/2017/10/30/CIR.0000000000000550
Fred M. Kusumoto

Jul 31st, 2018 - Our analysis has 2 objectives. First, to evaluate whether ventricular arrhythmias (VAs) induced with programmed electrostimulation in asymptomatic patients with Brugada syndrome identify a higher risk group that may require additional testing or t.

see more →

Clinicaltrials.gov  2,095 results

Clinical significance of inferolateral early repolarisation and late potentials in chil...
https://doi.org/10.1016/j.jelectrocard.2021.03.011
Journal of Electrocardiology; Lopez-Blazquez M, Field E et. al.

Apr 8th, 2021 - The clinical utility of inferolateral early repolarisation (ER) and late potentials (LP) in children with Brugada Syndrome (BrS) has not been previously evaluated. The aim of this study was to determine the prevalence of electrocardiographic (ECG)...

Single Cell Transcriptomics Trajectory and Molecular Convergence of Clinically Relevant...
https://doi.org/10.1152/ajpheart.00061.2021
American Journal of Physiology. Heart and Circulatory Phy... Tambi R, Abdel Hameid R et. al.

Apr 2nd, 2021 - Brugada syndrome (BrS) is a rare, inherited arrhythmia with high risk of sudden cardiac death. To evaluate the molecular convergence of clinically relevant mutations and to identify developmental cardiac cell types that are associated with BrS eti...

A 32-Year-Old Man Diagnosed with Type II Brugada Syndrome on Preoperative Electrocardio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988432
The American Journal of Case Reports; Yuasa H, Kitaura A et. al.

Mar 19th, 2021 - BACKGROUND Brugada syndrome is a potentially fatal cardiac arrhythmia characterized by incomplete right bundle-branch block (RBB) and characteristic ST-segment elevation in the anterior electrocardiogram (ECG) leads. This report is of a case of ty...

Right ventricular function and dyssynchrony in Brugada syndrome: Highlighting the impor...
https://doi.org/10.1016/j.ijcard.2021.03.014
International Journal of Cardiology; Mitroi C, García-Izquierdo E et. al.

Mar 17th, 2021 - Current evidence suggests that Brugada syndrome (BrS), far from being a purely electrical condition, is associated with subtle mechanical abnormalities primarily affecting the right ventricle (RV). We aimed to characterize RV function in BrS and i...

Structure of human Nav1.5 reveals the fast inactivation-related segments as a mutationa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980460
Proceedings of the National Academy of Sciences of the Un... Li Z, Jin X et. al.

Mar 13th, 2021 - Nav1.5 is the primary voltage-gated Na+ (Nav) channel in the heart. Mutations of Nav1.5 are associated with various cardiac disorders exemplified by the type 3 long QT syndrome (LQT3) and Brugada syndrome (BrS). E1784K is a common mutation that ha...

see more →

News  59 results

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.staging.medscape.com/viewarticle/940327

Nov 3rd, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.medscape.com/viewarticle/940327

Nov 3rd, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Brugada Genes Debunked; T2D Drug Excuses; Paradise Pivotal Trial
https://www.medpagetoday.com/cardiology/prevention/73911

Jul 8th, 2018 - A study reevaluating genes reported to be associated with Brugada syndrome challenged the validity of all but one. (Circulation) The American College of Cardiology renamed its ACTION Registry under the National Cardiovascular Data Registry umbrell...

Study: ICD Therapy Effective in Brugada Syndrome Long-Term
https://www.medpagetoday.com/cardiology/arrhythmias/68461

Oct 10th, 2017 - Action Points Long-term follow-up of Brugada syndrome patients confirmed the efficacy of implanted cardioverter-defibrillator (ICD) devices but also substantial adverse event risk. The predictors of appropriate therapy were a type 1 electrocardiog...

Absorb Stent Off Market; 9/11 Dust Lipid Effects; New AUC in Valvular Imaging
https://www.medpagetoday.com/cardiology/prevention/67813

Sep 11th, 2017 - The Absorb bioresorbable stent will come rapidly off the market worldwide due to poor sales, Abbott announced, although the firm may return with a second-generation device. MedPage Today has the full story here. Kids' exposure to chemical-laden du...

see more →

Patient Education  7 results see all →